A University of Pittsburgh School of Medicine research team, collaborating with scientists from Stanford University, have developed a new, smaller gene therapy vector that may be effective in delivering a radioprotective enzyme systemically throughout the body which may spare healthy tissue the long-term consequences of therapeutic irradiation.
Researchers in endocrinology and obstetrics and gynecology at Cedars-Sinai Medical Center will make several presentations at the upcoming annual meetings of two medical organizations ? the Androgen Excess Society (June 1, 2007) and the Endocrine Society (June 2-5, 2007).
The U.S. Food and Drug Administration (FDA) today approved Torisel (temsirolimus) for the treatment of a certain type of advanced kidney cancer known as renal cell carcinoma.
The results of a phase III, randomized clinical study involving patients with advanced renal cell carcinoma and poor prognostic features show temsirolimus improved overall survival when compared to the current treatment for this stage of disease.
Why do older people tend to lose muscle mass and grow frail? One important factor identified by medical science is the reduced ability of the elderly to respond to the muscle-building stimulus of the hormone insulin.
Physician assistants (Pas) addressed a broad range of issues ? including overcrowding in emergency departments, retail clinics, reparative therapy, retail-based clinics, deceptive health care advertising, and apologizing for adverse outcomes ? during the 35th annual conference of the American Academy of Physician Assistants (AAPA), meeting in Philadelphia through May 31.
A new study showing that growth factors and the environment combine to increase brain maturation appears in the May 30th issue of the online, open-access journal PLoS ONE.
A natural compound found in blueberries, tea, grapes and cocoa enhances memory in mice, according to newly published research. This effect increased further when mice also exercised regularly.
New early data showed that an investigational device that specifically targets rapidly growing cancer cells with intermediate frequency electrical fields — called Tumor-Treating Fields (TTFields) — more than doubled the median overall survival rates in patients with recurrent glioblastoma multiforme (GBM), the most common and aggressive type of malignant brain tumor.
Starting with blood of patients who survived a bout of avian flu (infection with the H5N1 strain), Cameron Simmons (of the Oxford University Clinical Research Unit at the Hospital for Tropical Diseases in Ho Chi Minh City, Vietnam) and colleagues generated neutralizing human monoclonal antibodies and show that they can halt viral growth in mice deliberately infected with H5N1 virus.